Terms: = Endocrine gland cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Staging
16 results:
1. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.
Sohn AJ; Taherian M; Katz MHG; Prakash LR; Chatterjee D; Wang H; Kim M; Tzeng CD; Lee JE; Ikoma N; Rashid A; Wolff RA; Zhao D; Koay EJ; Sun R; Maitra A; Wang H
Am J Surg Pathol; 2023 Apr; 47(4):421-430. PubMed ID: 36746143
[TBL] [Abstract] [Full Text] [Related]
2. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.
Wei D; Zaid MM; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Agrawal A; Rashid A; Wang H; Varadhachary G; Wolff RA; Tamm EP; Bhosale PR; Maitra A; Koay EJ; Wang H
Pancreatology; 2021 Jan; 21(1):200-207. PubMed ID: 33221151
[TBL] [Abstract] [Full Text] [Related]
4. Imaging spectrum of NUT carcinomas.
Virarkar M; Saleh M; Ramani NS; Morani AC; Bhosale P
Clin Imaging; 2020 Nov; 67():198-206. PubMed ID: 32866821
[TBL] [Abstract] [Full Text] [Related]
5. Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.
Xu B; Ghossein RA
Histopathology; 2018 Jan; 72(1):32-39. PubMed ID: 28782127
[TBL] [Abstract] [Full Text] [Related]
6. Functional Assessment of Synoptic Pathology Reporting for Ovarian cancer.
Słodkowska J; Cierniak S; Patera J; Kopik J; Baranowski W; Markiewicz T; Murawski P; Buda I; Kozłowski W
Pathobiology; 2016; 83(2-3):70-8. PubMed ID: 27100104
[TBL] [Abstract] [Full Text] [Related]
7. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
8. Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists.
Urken ML; Mechanick JI; Sarlin J; Scherl S; Wenig BM
Endocr Pathol; 2014 Sep; 25(3):214-8. PubMed ID: 24292975
[TBL] [Abstract] [Full Text] [Related]
9. Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer.
Murgić J; Prpić M; Kirac I; Camino-Varela AM; Bolanca A; Kusić Z
Coll Antropol; 2012 Mar; 36(1):325-9. PubMed ID: 22816241
[TBL] [Abstract] [Full Text] [Related]
10. [Radical procedures in patients with pancreatic cancer--impact on prolongation and quality of life].
Ryska M
Rozhl Chir; 2010 Dec; 89(12):725-30. PubMed ID: 21404511
[TBL] [Abstract] [Full Text] [Related]
11. Update to the College of American Pathologists reporting on thyroid carcinomas.
Ghossein R
Head Neck Pathol; 2009 Mar; 3(1):86-93. PubMed ID: 20596997
[TBL] [Abstract] [Full Text] [Related]
12. Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
Buck AC; Schirrmeister HH; Guhlmann CA; Diederichs CG; Shen C; Buchmann I; Kotzerke J; Birk D; Mattfeldt T; Reske SN
J Nucl Med; 2001 May; 42(5):721-5. PubMed ID: 11337566
[TBL] [Abstract] [Full Text] [Related]
13. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
Wang PH; Yuan CC; Shyong WY; Chiang SC; Chao JY; Yen MS; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):220-5. PubMed ID: 10746418
[TBL] [Abstract] [Full Text] [Related]
14. How does negative clinical evaluation of ovarian carcinoma after full course of chemotherapy correlate with second-look laparotomy findings?
Zorlu CG; Cobanoglu O; Caglar T; Ergun Y; Kuscu E; Alaybeyoglu T
J Surg Oncol; 1994 Apr; 55(4):255-8. PubMed ID: 8159008
[TBL] [Abstract] [Full Text] [Related]
15. [Strategy for the ovarian cancer treatment].
Ochiai K
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2454-60. PubMed ID: 8279841
[TBL] [Abstract] [Full Text] [Related]
16. [Side effects and anti-cancer effects following intraperitoneal (ip) administration of mitomycin C (MMC)].
Takizawa K; Ino Y; Isono T; Sato M; Iguchi T; Takeda Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1877-83. PubMed ID: 3109329
[TBL] [Abstract] [Full Text] [Related]
